StockData
Embecta Corp. logo

Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.09−0.06 (-0.98%)

Close on Nov 18, 2026Market cap $345.06MP/E 4.1Yield 9.85%

Embecta net income

Net income is the profit left for shareholders after every expense, interest and tax.

Embecta's net income for the twelve months ending Jun 30, 2026 was $87.50M, up 4.7% year over year. For fiscal 2025 it was $95.40M, up 21.8% from the year before. The highest annual figure on record is $427.60M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Sep 30, 2025$95.40M+21.8%
FY2024Sep 30, 2024$78.30M+11.2%
FY2023Sep 30, 2023$70.40M-68.5%
FY2022Sep 30, 2022$223.60M-46.1%
FY2021Sep 30, 2021$414.80M-3.0%
FY2020Sep 30, 2020$427.60M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$21.10M-53.6%
Q2 FY2026CQ1 2026Mar 31, 2026-$4.10M-117.4%
Q1 FY2026CQ4 2025Dec 31, 2025$44.10M–
Q4 FY2025CQ3 2025Sep 30, 2025$26.40M+80.8%
Q3 FY2025CQ2 2025Jun 30, 2025$45.50M+209.5%
Q2 FY2025CQ1 2025Mar 31, 2025$23.50M-18.7%
Q1 FY2025CQ4 2024Dec 31, 2024$0-100.0%
Q4 FY2024CQ3 2024Sep 30, 2024$14.60M+143.3%
Q3 FY2024CQ2 2024Jun 30, 2024$14.70M-3.3%
Q2 FY2024CQ1 2024Mar 31, 2024$28.90M+106.4%
Q1 FY2024CQ4 2023Dec 31, 2023$20.10M-42.9%
Q4 FY2023CQ3 2023Sep 30, 2023$6.00M–
Q3 FY2023CQ2 2023Jun 30, 2023$15.20M-75.6%
Q2 FY2023CQ1 2023Mar 31, 2023$14.00M-82.4%
Q1 FY2023CQ4 2022Dec 31, 2022$35.20M-64.4%
Q4 FY2022CQ3 2022Sep 30, 2022-$17.20M-117.8%
Q3 FY2022CQ2 2022Jun 30, 2022$62.40M-40.4%
Q2 FY2022CQ1 2022Mar 31, 2022$79.60M-26.2%
Q1 FY2022CQ4 2021Dec 31, 2021$98.80M-6.2%
Q4 FY2021CQ3 2021Sep 30, 2021$96.90M–
Q3 FY2021CQ2 2021Jun 30, 2021$104.70M–
Q2 FY2021CQ1 2021Mar 31, 2021$107.90M–
Q1 FY2021CQ4 2020Dec 31, 2020$105.30M–

More Embecta figures

See a number that looks wrong?